Sue Hamke is Silverback’s vice president of clinical operations. Ms. Hamke has over 25 years of experience in clinical operations in the biotechnology and pharmaceutical industry, spanning first-in-human through registrational studies. She has experience in developing strong teams and successful study execution and has contributed to development programs that have resulted in four marketed products. Prior to working at Silverback, Ms. Hamke held senior level positions at Seattle Genetics and Cascadian Therapeutics where she oversaw all aspects of clinical operations for the tucatinib program. Prior to Cascadian, Ms. Hamke held positions of increasing responsibility in clinical trial monitoring and management at Acucela, Fred Hutchinson Cancer Research Center, Pharmion (UK), Hoechst Marion Roussel, and PRA. Ms. Hamke received her B.S. from the University of Maine and M.S. from Northeastern University in Boston.